Cannaisseur Group Narrows Q1 Loss to $10K Amid Zero Revenue
Ticker: TCRG · Form: 10-Q · Filed: Jul 21, 2025 · CIK: 1879270
| Field | Detail |
|---|---|
| Company | Cannaisseur Group Inc. (TCRG) |
| Form Type | 10-Q |
| Filed Date | Jul 21, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: Pre-Revenue, Micro-Cap, Emerging Growth Company, High Risk, Biotech, Quarterly Report, SEC Filing
TL;DR
TCRG is a pre-revenue penny stock with no clear path to profitability; avoid unless you're a high-risk speculator.
AI Summary
Cannaisseur Group Inc. (TCRG) reported no revenue for the three months ended March 31, 2025, consistent with the prior year period. The company incurred a net loss of $10,000 for the quarter, a significant improvement from the $1,000,000 net loss reported for the same period in 2024. This reduction in net loss was primarily due to decreased operating expenses. The company continues to operate as a smaller reporting company and an emerging growth company, indicating its early stage of development. There were no significant business changes or strategic outlooks detailed in this filing, beyond the ongoing efforts to manage operational costs. The primary risk highlighted is the lack of revenue generation and the continued reliance on external financing to cover its minimal operating expenses. The company's financial position remains precarious with no income-generating operations.
Why It Matters
For investors, TCRG's continued lack of revenue and minimal operations signal a highly speculative investment, relying entirely on future business development. Employees, if any beyond management, face significant job insecurity given the company's early stage and lack of income. Customers are currently non-existent as the company has no products or services generating revenue. In the broader market, TCRG represents a micro-cap entity struggling to establish a foothold in the medicinal chemicals and botanical products sector, a competitive space dominated by larger, established players. Its inability to generate revenue puts it at a severe disadvantage.
Risk Assessment
Risk Level: high — The risk level is high because Cannaisseur Group Inc. reported no revenue for the quarter ended March 31, 2025, and incurred a net loss of $10,000. The company is a 'smaller reporting company' and an 'emerging growth company,' indicating its early stage and inherent operational and financial instability.
Analyst Insight
Investors should exercise extreme caution and consider avoiding TCRG shares given its pre-revenue status and ongoing losses. This company is suitable only for investors with a very high-risk tolerance looking for highly speculative opportunities, and even then, significant due diligence on future business plans is essential.
Financial Highlights
- debt To Equity
- N/A
- revenue
- $0
- operating Margin
- N/A
- total Assets
- N/A
- total Debt
- N/A
- net Income
- -$10,000
- eps
- N/A
- gross Margin
- N/A
- cash Position
- N/A
- revenue Growth
- 0.0%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Total Revenue | $0 | 0.0% |
Key Numbers
- $0 — Revenue (No revenue generated for the quarter ended March 31, 2025, consistent with the prior year.)
- -$10,000 — Net Loss (Significantly reduced from a $1,000,000 net loss in the prior year period.)
- March 31, 2025 — Reporting Period End (The specific quarter covered by this 10-Q filing.)
Key Players & Entities
- Cannaisseur Group Inc. (company) — registrant of the 10-Q filing
- SEC (regulator) — recipient of the 10-Q filing
- $10,000 (dollar_amount) — net loss for the quarter ended March 31, 2025
- $1,000,000 (dollar_amount) — net loss for the quarter ended March 31, 2024
- Delaware (company) — state of incorporation for Cannaisseur Group Inc.
- Atlanta, GA (company) — business address for Cannaisseur Group Inc.
- 000-56664 (regulator) — Commission File Number for Cannaisseur Group Inc.
- March 31, 2025 (date) — end of the reported quarterly period
FAQ
What was Cannaisseur Group Inc.'s revenue for the quarter ended March 31, 2025?
Cannaisseur Group Inc. reported no revenue for the quarter ended March 31, 2025, which is consistent with the zero revenue reported for the same period in the prior year.
How much was Cannaisseur Group Inc.'s net loss for Q1 2025?
Cannaisseur Group Inc. incurred a net loss of $10,000 for the three months ended March 31, 2025, a substantial improvement from the $1,000,000 net loss in the comparable period of 2024.
Is Cannaisseur Group Inc. considered a smaller reporting company?
Yes, Cannaisseur Group Inc. indicated in its 10-Q filing that it is a smaller reporting company, as well as an emerging growth company.
What is the primary business of Cannaisseur Group Inc.?
Based on its Standard Industrial Classification (SIC) code 2833, Cannaisseur Group Inc. operates in the Medicinal Chemicals & Botanical Products sector, although the filing indicates no current revenue-generating operations.
What is the address of Cannaisseur Group Inc.?
The business address for Cannaisseur Group Inc. is 650 Ponce De Leon Ave, Suite 300 #2334, Atlanta, GA 30308.
What is the fiscal year end for Cannaisseur Group Inc.?
Cannaisseur Group Inc.'s fiscal year ends on December 31, as stated in the company data section of the filing.
Has Cannaisseur Group Inc. filed all required reports with the SEC?
Yes, the company indicated by checkmark that it has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months.
What is the significance of Cannaisseur Group Inc. being an 'emerging growth company'?
As an 'emerging growth company,' Cannaisseur Group Inc. is subject to reduced reporting requirements and may have an extended transition period for complying with new or revised financial accounting standards, as per Section 13(a) of the Exchange Act.
What are the main risks associated with investing in Cannaisseur Group Inc.?
The main risks include the company's pre-revenue status, ongoing net losses (despite reduction), and its classification as a smaller reporting and emerging growth company, all indicating significant operational and financial uncertainty.
What was the previous name of Cannaisseur Group Inc.?
The former conformed name of the company was Cannasieur Group Inc., with the name change occurring on August 19, 2021.
Risk Factors
- Lack of Revenue Generation [high — financial]: The company reported $0 in revenue for the three months ended March 31, 2025, and the prior year period. This ongoing lack of revenue generation poses a significant financial risk, as it necessitates continued reliance on external financing to cover operational expenses.
- Reliance on External Financing [high — financial]: With no revenue-generating operations, Cannaisseur Group Inc. relies entirely on external financing to fund its minimal operating expenses. This dependence creates vulnerability to changes in investor sentiment and the availability of capital.
- Early Stage of Development [medium — operational]: The company is classified as a smaller reporting company and an emerging growth company. This indicates an early stage of development, which often comes with inherent operational risks and uncertainties regarding long-term viability and scalability.
Industry Context
Cannaisseur Group Inc. operates within the medicinal chemicals and botanical products sector (SIC 2833). This industry can be highly competitive and is subject to evolving regulatory landscapes, particularly concerning botanical products. Companies in this space often face challenges related to research and development, product commercialization, and market access.
Regulatory Implications
As a smaller reporting and emerging growth company, TCRG benefits from scaled disclosure requirements. However, its classification within the medicinal chemicals and botanical products sector may expose it to specific industry-related regulations concerning product safety, efficacy, and marketing, depending on its specific product lines.
What Investors Should Do
- Monitor for revenue generation strategies.
- Assess the sustainability of external financing.
- Evaluate operational cost management.
Key Dates
- 2025-03-31: Quarterly Period End — Marks the end of the reporting period for the 10-Q filing, providing financial and operational data for the preceding three months.
- 2025-07-21: 10-Q Filing Date — The date the company officially submitted its quarterly report to the SEC, making the information publicly available.
Glossary
- Smaller Reporting Company
- A company that meets certain criteria related to public float and annual revenues, allowing for scaled disclosure requirements. (Indicates TCRG's size and regulatory status, suggesting a less mature business with potentially fewer resources.)
- Emerging Growth Company
- A company that has total annual gross revenues of less than $1.235 billion during its most recently completed fiscal year and meets other criteria, allowing for certain exemptions from regulatory requirements. (Highlights TCRG's early stage of development and potential for future growth, but also implies ongoing risks associated with new ventures.)
- 10-Q
- A quarterly report required by the U.S. Securities and Exchange Commission (SEC) that provides a continuing view of a company's financial position during the year. (This document provides the latest financial update for TCRG, crucial for understanding its current operational status and performance.)
Year-Over-Year Comparison
For the three months ended March 31, 2025, Cannaisseur Group Inc. reported $0 in revenue, consistent with the prior year period. The company significantly reduced its net loss to $10,000 from $1,000,000 in the same period last year, primarily driven by decreased operating expenses. No new significant risks were detailed, but the core risks of no revenue generation and reliance on external financing remain prominent.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on July 21, 2025 regarding Cannaisseur Group Inc. (TCRG).